Concept Foundation is supporting access to safe medical abortion in Argentina

Jan 6, 2021 | Global news, Safe Abortion

In a landmark ruling, a restrictive abortion law that had been in place since 1921 was overturned by the Argentinian upper senate on 30th December 2020, in favour of legalising abortion up to 14 weeks. This new law comes two years after the senate narrowly voted against legalizing abortion in 2018.

During 2020 Concept Foundation has been working closely with Centro de Estudios de Estado y Sociedad (CEDES), a national NGO who have played an important role in supporting Ministry of Health (MoH) planning around the establishment and implementation of abortion services in the country. In the context of this window of opportunity, Concept and CEDES have been assisting the government to prepare for the availability of quality medical abortion medicines and care in support of the new law in compliance with WHO’s recommended policies, guidelines and protocols.

With an Innovation Fund grant from the Reproductive Health Supplies Coalition (RHSC), Concept Foundation and CEDES are conducting an ongoing market assessment to identify possible barriers that hinder access to quality medical abortion supplies and care and establish the platform for the introduction of medical abortion medicines. Later in the year we will convene key stakeholders to develop a series of recommendations and seek Ministry of Health endorsement for developing a strategy to implement new guidelines.

At the same time, at the request of the Ministry of Health, Concept Foundation has been engaging and providing technical advice to the Argentinian pharmaceutical industry on the manufacture of quality-assured medical abortion medicines, an activity undertaken with support from WHO under our collaborative project “Improving the Availability of Co-Packaged Mifepristone and Misoprostol in lower and middle-income countries”. With the passing of the new law, we will be increasing the scope of this activity and level of support to local manufacturing in Argentina with the objective of ensuring access to quality-assured and affordable medical abortion medicines for women and girls in Argentina.